These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10139403)

  • 21. ["Managed care in Germany--social rights and economic aspects of possible adoption"].
    Pilgrim S; Pilgrim TB
    Gesundheitswesen; 1999 Oct; 61(10):487-8. PubMed ID: 10593053
    [No Abstract]   [Full Text] [Related]  

  • 22. Managed care and diabetes, with special attention to the issue of who should provide care.
    Quickel KE
    Trans Am Clin Climatol Assoc; 1997; 108():184-95; discussion 196-9. PubMed ID: 9108677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special report: Putting outcomes management to the test--from theory to practice.
    Bus Health; 1996 Nov; 14(11 Suppl A):6-30. PubMed ID: 10156160
    [No Abstract]   [Full Text] [Related]  

  • 24. Managed care: imaging issues and impact.
    Schwartz HW
    Radiol Manage; 1994; 16(1):23-34. PubMed ID: 10132553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced costing of patient care.
    Samuel G
    Healthc Inform; 1994 Dec; 11(12):74, 76, 78. PubMed ID: 10139233
    [No Abstract]   [Full Text] [Related]  

  • 26. Disease management: continuous health-care improvement.
    Terry K
    Bus Health; 1995 Apr; 13(4):64-9, 72. PubMed ID: 10152743
    [No Abstract]   [Full Text] [Related]  

  • 27. Advancing economic evaluations of drug therapy.
    Navarro RP
    Med Interface; 1996 Jul; 9(7):86-7, 92. PubMed ID: 10159281
    [No Abstract]   [Full Text] [Related]  

  • 28. Strategies to control costs and quality: a focus on outcomes research for disease management.
    Villagra V
    Med Care; 2004 Apr; 42(4 Suppl):III24-30. PubMed ID: 15026668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed care's atypical response. New antipsychotics show promise, but are they getting into enough hands?
    Waldron T
    Behav Healthc Tomorrow; 1999 Apr; 8(2):28-31. PubMed ID: 10351297
    [No Abstract]   [Full Text] [Related]  

  • 30. DM vendors start to address costs created by comorbidities.
    Carroll J
    Manag Care; 2002 Mar; 11(3):42A-42B, 42E. PubMed ID: 11928243
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer carve outs and outcomes measurement programs: an emerging paradigm.
    Kurowski B
    Med Interface; 1996 Nov; 9(11):81-4. PubMed ID: 10162564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives. DSM: a concept coming into focus.
    Moss K
    Faulkner Grays Med Health; 1996 Aug; 50(32):suppl 1-4. PubMed ID: 10159011
    [No Abstract]   [Full Text] [Related]  

  • 33. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An industry in evolution.
    Blissenbach HF
    Med Interface; 1995 Oct; 8(10):80-1, 88. PubMed ID: 10152328
    [No Abstract]   [Full Text] [Related]  

  • 38. Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.
    Santos R; Cifaldi M; Gregory C; Seitz P
    Am J Manag Care; 1999 Apr; 5(4 Suppl):S225-34. PubMed ID: 10387543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research agenda: emerging issues in the management of health and illness.
    Biordi DL
    Semin Nurse Manag; 2000 Dec; 8(4):205-11. PubMed ID: 12029670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.